NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 – Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024
Press Releases
November 26, 2024

NRx Pharmaceuticals (NASDAQ: NRXP) Announces Participation in the NobleCon20 – Noble Capital Markets’ Twentieth Annual Emerging Growth Equity Conference December 3-4, 2024

WILMINGTON, Del., Nov. 26, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Dr. Jonathan Javitt, Chairman, CEO and Chief

bradford

The Bradford Era

More by this Author
Local & Social